End-stage rheumatoid arthritis: specific features of patient management
The paper provides data on the treatment of patients with end-stage rheumatoid arthritis (RA) and a rationale for the long-term treatment with disease-modifying antirheumatic drugs, including leflunomide as a first-line agent. It describes a clinical case of a patient with end-stage RA during arava...
Main Authors: | Nadezhda Aleksandrovna Shostak, A A Klimenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2013-06-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/483 |
Similar Items
-
RESULTS OF AN OPEN CLINICAL STUDY OF THE EFFICACY OF LEFLUNOMIDE IN RHEUMATOID ARTHRITIS
by: I M Marusenko
Published: (2009-06-01) -
Rheumatoid arthritis: problems of treatment at the present stage
by: N. V. Chichasova
Published: (2018-12-01) -
Leflunomide in clinical practice
by: Yuriy Aleksandrovich Olyunin
Published: (2014-03-01) -
Evaluation of the efficacy of standard basic anti-inflammatory drugs and the time to start basictherapy for rheumatoid arthritis
by: Irina Mikhailovna Marusenko
Published: (2010-12-01) -
Efficiency and safety of leflunomide in rheumatoid arthritis: Results of a Russian observational multicenter of trial
by: R. M. Balabanova, et al.
Published: (2015-06-01)